KAYLA SHERMAN: Open Payments
NPI 1710572458 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $60 |
| Alkermes, Inc. | 2 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: VRAYLAR, INGREZZA, COBENFY, VIVITROL, ARISTADA, FANAPT.
Industry payments across CO — which companies pay providers there.
